Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization
Open Access
- 1 January 2015
- journal article
- case report
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 10 (4) , 484-6
Abstract
To report a patient with juxtapapillary choroidal osteoma (CO) with serous retinal detachment (SRD) not associated with choroidal neovascularization (CNV) who was successfully treated with a single intravitreal injection of bevacizumab. A 20-year-old woman presented with decreased vision in her right eye. Ultrasonography, fundus autofluorescence, fluorescein angiography (FA) and optical coherence tomography (OCT) were performed. She was diagnosed with juxtapapillary CO with SRD in the absence of CNV. The treatment involved a single intravitreal injection of bevacizumab. Visual acuity (VA) was 20/100 pre-injection which was dramatically improved to 20/20 one week after the injection without any additional treatment. Fundus examination and OCT one week after the injection revealed complete absorption of the subretinal fluid (SRF) in the macula. Eighteen months after the injection, vision remained stable and she did not show re-accumulation of SRF in her right eye. Intravitreal injection of bevacizumab may be effective in managing CO associated with SRF without CNV.Keywords
This publication has 17 references indexed in Scilit:
- Fundus Autofluorescence Imaging Findings in Choroidal OsteomaRetina, 2011
- Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumabClinical Ophthalmology, 2010
- INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF SUBRETINAL FLUID ASSOCIATED WITH CHOROIDAL OSTEOMARetina, 2010
- Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin)Graefe's Archive for Clinical and Experimental Ophthalmology, 2007
- Intravitreal Bevacizumab for Choroidal Neovascularization Caused by AMD (IBeNA Study): Results of a Phase 1 Dose-Escalation StudyInvestigative Ophthalmology & Visual Science, 2006
- Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular DegenerationAmerican Journal of Ophthalmology, 2006
- Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular DegenerationOphthalmology, 2006
- Factors Predictive of Tumor Growth, Tumor Decalcification, Choroidal Neovascularization, and Visual Outcome in 74 Eyes With Choroidal OsteomaArchives of Ophthalmology (1950), 2005
- A Long-term Follow-up of Choroidal OsteomaArchives of Ophthalmology (1950), 1998
- Choroidal osteomaSurvey of Ophthalmology, 1988